List of American Medical Association journals

Think tank’ develops proposals to leverage precision medicine to improve cholangiocarcinoma patient outcomes

Retrieved on: 
Tuesday, October 25, 2022
Quality of life, Method, Lung, Caregiver, Cholangiocarcinoma, Stent, Sidney Kimmel, Disease, Therapy, Bile duct, Neoplasm, Bile, Diagnosis, Science, List of American Medical Association journals, Education, JAMA Network Open, Foundation, Patient, Biology, Primary sclerosing cholangitis, Research, Colonoscopy, Sidney Kimmel Comprehensive Cancer Center, Precision medicine, Cancer, Gallbladder, Roy Taylor (scientist), Incidence, Awareness, Liver, Survival, GLOBE, Smoker, CCA, PSC, CCF, Cohort study, Leadership, Medical device, Medical imaging, Pharmaceutical industry, Vaccine

This effort, made possible by generous philanthropic donations to the Cholangiocarcinoma Foundation , was the first of its kind in the cholangiocarcinoma (CCA) field.

Key Points: 
  • This effort, made possible by generous philanthropic donations to the Cholangiocarcinoma Foundation , was the first of its kind in the cholangiocarcinoma (CCA) field.
  • The primary themes precision prevention, early detection, and precision therapeutics reflected areas of urgency and opportunity for improving outcomes for people impacted by CCA.
  • Cholangiocarcinoma is a type of cancer that forms in the slender tubes called bile ducts that carry the digestive fluid bile.
  • Its mission is to find a cure for cholangiocarcinoma (bile duct cancer) and improve the quality of life for patients.

C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments

Retrieved on: 
Friday, October 21, 2022
Research, General Health, Biometrics, Consumer, Mental Health, Genetics, Clinical Trials, Science, Neurology, Biotechnology, Seniors, Health, Other Science, Fillit, CAP, ISO, Health, Union, Time, AARP, Memory, Randall, CE marking, Amnesia, Accreditation, Disease, Efficiency, Conference, Diagnosis, Accreditation Committee of Cambodia, Molecular Neurodegeneration, COVID, JAMA Network Open, Cognition, List of American Medical Association journals, Patient, Center for Epidemiologic Studies Depression Scale, Research, Alzheimer's disease, Entrepreneurship, Clarity, Dementia, Technology, Automation, Certification, Clinica Chimica Acta, Washington University in St. Louis, Trial of the century, Davos, Magazine, LC-MS/MS, College, American Medical Association, News, Clinical trial, PET, Eisai, NBC News, Biogen, Neurodegeneration, Medical device, Medical imaging, Pharmaceutical industry, Brain

The company boldly launched the PrecivityAD blood test during the height of the COVID pandemic in October 2020.

Key Points: 
  • The company boldly launched the PrecivityAD blood test during the height of the COVID pandemic in October 2020.
  • Molecular Neurodegeneration was the first to distribute a research paper that stated the PrecivityAD blood test can accurately identify brain amyloid status based on a single blood sample.
  • AARP The Magazine reported on Shelby Hileman, who also received an Alzheimers diagnosis after her doctor reviewed her PrecivityAD blood test result.
  • In a TV story , a wife shared why her husband decided to take the PrecivityAD blood test after his doctor recommended it.

Spring Health Launches New Behavioral Health Partnership with Moda Health

Retrieved on: 
Tuesday, October 18, 2022
General Mills, Mental health, Moda Health, Delta Dental, Meditation, Population, List of American Medical Association journals, JAMA Network Open, Health, Patient, Instacart, Kaiser Family Foundation, Multimedia, Partnership, Technology, Behavior, Emergency Health Services, DocuSign, View, Ageing, Health minister, Depression, ODS, Absenteeism, Health insurance, Medicine

NEW YORK, Oct. 18, 2022 /PRNewswire/ -- Spring Health, the most comprehensive global mental health solution for employers and health plans, today announced its agreement with Moda Health to deliver measurement-based mental health care to select employer groups through Moda's innovative Behavioral Health 360 platform. The new partnership expands Spring Health's offering into the payer and health plan market.

Key Points: 
  • NEW YORK, Oct. 18, 2022 /PRNewswire/ -- Spring Health , the most comprehensive global mental health solution for employers and health plans, today announced its agreement with Moda Health to deliver measurement-based mental health care to select employer groups through Moda's innovative Behavioral Health 360 platform.
  • Moda Health is a regional health plan providing health insurance to employers across Idaho, Alaska, Texas, Oregon, and Washington.
  • "Moda has always sought to stay out front in providing best-in-class behavioral health services for our members," said Dan Thoma, Director of Behavioral Health at Moda.
  • The Moda family of enterprises includes Moda Health, Ardon Health, Arrow Dental, Astra Practice Partners, BenefitHelp Solutions, Eastern Oregon Coordinated Care Organization, Emerging Health, Moda Assurance Company, ODS Community Dental, OHSU Health IDS, and Summit Health.

Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor

Retrieved on: 
Tuesday, September 20, 2022
Biotechnology, Pharmaceutical, Health, Oncology, Adult, Texas Oncology, Paclitaxel, Journal, List of American Medical Association journals, Adenosine, UPMC, Research, Baylor University Medical Center, Woman, Patient, Liu v. Securities and Exchange Commission, Translational research, Acute myeloid leukemia, NASDAQ, Takeda, Tablet, Food, EDT, Lymphoma, Division, Puma Biotechnology, European Commission, Aurora kinase, Annual report, Founder, Head, Doctor of Philosophy, Associate, Squamous cell carcinoma, Triple-negative breast cancer, Apoptosis, Investor, Puma, MD, FDA, Capecitabine, Neoplasm, Ovarian cancer, Breast cancer, Biotechnology, Thorax, Security (finance), Conference, UPMC Hillman Cancer Center, Aurora, Mitosis, Fulvestrant, Regulation of tobacco by the U.S. Food and Drug Administration, Risk, Royal commission, Cancer, Pharmaceutical industry, Medical imaging, Alisertib

Under the terms of the agreement, Puma will assume sole responsibility for the global development and commercialization of alisertib.

Key Points: 
  • Under the terms of the agreement, Puma will assume sole responsibility for the global development and commercialization of alisertib.
  • Puma will host a conference call today at 2:00 p.m. PDT/5:00 p.m. EDT to discuss the alisertib licensing agreement.
  • Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care.
  • Puma in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.

COVID-19 Vaccination Rates at NYC Schools Varied Significantly by Race/Ethnicity and Borough

Retrieved on: 
Thursday, September 15, 2022
MPH, National, NINR, White and Black: Crimes of Color, Gaps, Department, COVID-19, List of American Medical Association journals, Policy, Mental Hygiene, NYU Langone Health, New York City Department of Health and Mental Hygiene, Administration, 2009 Davis Cup, Department of Health and Mental Hygiene, Vaccination, Nursing Research, University of Delaware, White, National Institute of Nursing Research, Syracuse University, Student, Vaccine, JAMA Network Open, NYU, Population health, Public policy, Black, School, Research, School of Public Policy and Administration, University, New York University Grossman School of Medicine, Pharmaceutical industry, Tutoring, MD, COVID, Doctor of Philosophy, Medicine

Lagging furthest behind in COVID vaccination rates were schools attended by majority White and Black students, at 44 percent, while schools in Staten Island had lower vaccination rates, on average, than in any other borough.

Key Points: 
  • Lagging furthest behind in COVID vaccination rates were schools attended by majority White and Black students, at 44 percent, while schools in Staten Island had lower vaccination rates, on average, than in any other borough.
  • Reporting in the journal JAMA Network Open online September 15, after examining data from more than 1,500 NYC schools with an average of 980 students, the research team found that vaccination rates varied significantly by borough, ranging from the highest in Manhattan (59.7 percent) and lowest in Staten Island (38.6 percent).
  • Additionally, the researchers found that middle-high schools were more highly vaccinated (64.9 percent) than elementary schools (38.8 percent).
  • When broken down further, the data showed that while majority Asian schools had the highest vaccination rates regardless of borough, majority White schools in Manhattan (61.9 percent) and Brooklyn (49.1 percent) were more highly vaccinated than majority White schools in the Bronx (34.1 percent), Queens (28.5 percent), or Staten Island (25.4 percent).

New Study by Lunit and MGH Validates Effectiveness of AI as Aid in Chest X-Ray Interpretation - Published in JAMA Network Open

Retrieved on: 
Tuesday, September 13, 2022
Efficiency, List of American Medical Association journals, Hospital, CXR, Pneumothorax, Massachusetts General Hospital, Radiology, Patient, CEO, Pneumonia, Pleural effusion, JAMA Network Open, National Association Medical Staff Services, Indian Medical Association, American Medical Association, Research, KRX, MGH, Multimedia, AI, Medical device, Medical imaging

SEOUL, South Korea, Sept. 13, 2022 /PRNewswire/ -- A recent study published in JAMA Network Open demonstrated that Lunit INSIGHT CXR, Lunit's AI-powered chest x-ray analysis solution, can significantly improve the accuracy and efficiency of radiologists diagnosing major chest findings.

Key Points: 
  • SEOUL, South Korea, Sept. 13, 2022 /PRNewswire/ -- A recent study published in JAMA Network Open demonstrated that Lunit INSIGHT CXR, Lunit's AI-powered chest x-ray analysis solution, can significantly improve the accuracy and efficiency of radiologists diagnosing major chest findings.
  • The study was conducted by Lunit (KRX: 328130.KQ) and Dr. Mannudeep K. Kalra of Massachusetts General Hospital (MGH) from April to November 2021.
  • With a total of 497 chest x-rays, researchers compared Lunit INSIGHT CXR's standalone performance, radiologists' assessments with AI and without AI, diagnosing pneumonia, pneumothorax, pleural effusion, and pulmonary nodules.
  • JAMA Network Openis an international peer-reviewed medical journal published by the American Medical Association, with an impact factor of 13.353.

Putting Care Back In Health Care Through NFT's And Blockchain

Retrieved on: 
Friday, September 2, 2022
Friction, Health, Health Affairs, Solution, Medicine, Ink, List of American Medical Association journals, Non-fungible token, Patent, Smart contract, Fraud, BIT, Asset, Efficiency, Cryptocurrency, Blockchain

Black Ink Tech subsidiary Paired Pharma Inc aims to "Put Care Back In Health Care" by utilizing blockchain, tokens, and NFTs to remove friction and provide immutable confirmed data to improve these admin processes, and reduce or eliminate fraud and patient encounter misclassification and thus ultimately save money which could result in lower health care costs to consumers.

Key Points: 
  • Black Ink Tech subsidiary Paired Pharma Inc aims to "Put Care Back In Health Care" by utilizing blockchain, tokens, and NFTs to remove friction and provide immutable confirmed data to improve these admin processes, and reduce or eliminate fraud and patient encounter misclassification and thus ultimately save money which could result in lower health care costs to consumers.
  • Ultimately, the platform makes the patient encounter experience easier and faster for both patient and health care professional allowing care, not paperwork, to become the priority.
  • Black Ink Tech has exclusively licensing 11 awarded patents this year alone related to NFTs, Blockchain, Smart Contracts, and Digital Assets.
  • Accessed August 30, 2021. https://www.healthaffairs.org/do/10.1377/hblog20200218.375060/full/
    Chernew M, Mintz H. Administrative Expenses in the US Health Care System - Why So High?

CCC Now Offering Subscriptions to the JAMA Network and The New England Journal of Medicine Through RightFind

Retrieved on: 
Tuesday, August 9, 2022
Professional Services, Science, Other Science, Other Professional Services, Research, List of American Medical Association journals, Copyright Clearance Center, The New England Journal of Medicine, Wellness Corporate Solutions, Academic Medicine (journal), Information management, Wiley, JAMA, CCC, Knowledge, Research, Compliance, Patient, NEJM, STM, JAMA Network Open, Partnership, Physician, AMA, Software, Medicine, Organization, Music, Medical device

Originating as a pilot program with Wiley , the Publisher Subscriptions through RightFind service lets these organizations switch from on-demand individual article purchases to enterprise subscriptions for prominent journals.

Key Points: 
  • Originating as a pilot program with Wiley , the Publisher Subscriptions through RightFind service lets these organizations switch from on-demand individual article purchases to enterprise subscriptions for prominent journals.
  • It also has functionality to easily purchase unsubscribed content, as well as tools for collaborating in a copyright-compliant way directly in the RightFind workflow.
  • Researchers get the convenience of staying in the RightFind workflow while publishers benefit from another channel for renewable subscription sales.
  • The JAMA Network brings JAMA together with JAMA Network Open and 11 specialty medical journals to offer enhanced access to the research, reviews, and opinions shaping the future of medicine.

American College of Lifestyle Medicine Named New Content Provider for American Medical Association Online Learning Platform

Retrieved on: 
Tuesday, August 2, 2022
American Medical Association, Conditional sentence, Licensure, Human, American College, Physician, Sudarshan K. Aggarwal, Learning, Hospital, Maintenance, Health, ACLM, FACC, Research, Radiology, List of American Medical Association journals, CME, Type 2 diabetes, Organization, Certification, THE, Society of Hospital Medicine, CE, Society, MS, Disease management, AMA, Degenerative disease, Academic Medicine (journal), Hospital medicine, Obesity, Medicine, MD

ST. LOUIS, Aug. 2, 2022 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine (ACLM) announced today that it has become a content provider of educational courses to AMA Ed Hub™, the American Medical Association's (AMA) comprehensive online learning platform that supports the learning, licensure and certification needs of physicians and other health professionals.

Key Points: 
  • ST. LOUIS, Aug. 2, 2022 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine (ACLM) announced today that it has become a content provider of educational courses to AMA Ed Hub , the American Medical Association's (AMA) comprehensive online learning platform that supports the learning, licensure and certification needs of physicians and other health professionals.
  • ACLM joins other well-known organizations such as the JAMA Network, the American College of Radiology and the Society of Hospital Medicine as AMA Ed Hub content providers, among many others.
  • Lifestyle medicine certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions.
  • ABOUT ACLM--The American College of Lifestyle Medicine is the nation's medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health.

Nucleix Expands EU Label Indication of Bladder EpiCheck® to Include the Detection of Primary Bladder Cancer and Detection of Primary and Recurrent Upper Tract Urinary Cancer

Retrieved on: 
Wednesday, June 22, 2022
Biotechnology, Medical Devices, Health, Genetics, Oncology, Population, Union, Disease, Lung, Neoplasm, Malignancy, PCR, Bladder cancer, Life, Liquid biopsy, Technology, Cystoscopy, List of American Medical Association journals, DNA, Urinary bladder, Pathology, Squamous cell carcinoma, Ureter, Kidney, Triage, Recurrence, Medical Affairs Bureau, International Agency for Research on Cancer, NGS, Systematic review, Upper Tract, West Virginia, Organic, Erratum, Patient, IARC, Diagnosis, Blood, DNA methylation, The Journal of Urology, JAMA, Jurgis Matulaitis-Matulevičius, Research, Company, EMEA, UTUC, NPV, Sale, Medical imaging, Medical device, MD, Hematuria, Cancer, EU, Urine, Urology

With this expanded label indication and high specificity of Bladder EpiCheck in this population, were able to offer a cost-effective, non-invasive approach to triage hematuria patients and help identify bladder cancer early.

Key Points: 
  • With this expanded label indication and high specificity of Bladder EpiCheck in this population, were able to offer a cost-effective, non-invasive approach to triage hematuria patients and help identify bladder cancer early.
  • Bladder EpiCheck provides patients and clinicians with a simple, objective urine test to detect primary and recurrent bladder and upper urinary tract cancers.
  • Bladder EpiCheck is intended for use as a non-invasive method for detection of urinary tract cancers in conjunction with standard methods.
  • The Company is building an EpiCheck franchise, beginning with the Bladder EpiCheck testing kit, marketed in Europe for the detection of primary and recurrent bladder cancer and Upper Tract Urinary Cancer.